Nandrolone
is
chemically related
to
the
male hormone. Compared
to testosterone, it has an enhanced anabolic and
a reduced androgenic activity. This has
been demonstrated
in animal
bioassays and
explained
by
receptor binding studies. The low androgenicity of nandrolone is
confirmed in clinical use. In the human,
nandrolone has been shown to positively influence
calcium
metabolism and
to
increase bone
mass in osteoporosis. In women with disseminated mammary carcinoma, Nandrolone has
been reported to produce objective regressions for many months.
Furthermore,
Nandrolone
has
a
nitrogen-saving
action. This effect on protein metabolism
has been established by metabolic studies
and
is utilised
therapeutically
in conditions where a protein
deficiency
exists such as during chronic debilitating diseases
and
after major surgery and severe trauma. In these conditions, Nandrolone
Phenylpropionate
serves
as
a
supportive
adjunct to specific
therapies
and dietary measures as well as parenteral
nutrition, due to it's faster
acting nature Nandrolone phenylpropionate is preffered
in situations where
a
faster clinical
response is required over
it's chemical variant Nandrolone
decaonate.